Sarepta Therapeutics
SRPT
$130.26
Share price
1.46%
Change (1 day)
62.58%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Market capitalization of Sarepta Therapeutics (SRPT)
Market cap: $11.46 Billion
As of March 2023 Sarepta Therapeutics has a market cap of $11.46 Billion. This makes Sarepta Therapeutics the world's 1298th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sarepta Therapeutics from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $11.46 B | 0.75% |
| 2022 | $11.37 B | 45.06% |
| 2021 | $7.84 B | -41.72% |
| 2020 | $13.45 B | 38.67% |
| 2019 | $9.70 B | 25.09% |
| 2018 | $7.75 B | 115.68% |
| 2017 | $3.59 B | 140.16% |
| 2016 | $1.49 B | -14.94% |
| 2015 | $1.76 B | 194.49% |
| 2014 | $0.59 B | -22.27% |
| 2013 | $0.76 B | -5.98% |
| 2012 | $0.81 B | 708.83% |
| 2011 | $0.10 B | -57.54% |
| 2010 | $0.23 B | 47.65% |
| 2009 | $0.16 B | 244.53% |
| 2008 | $46.82 M | -48.47% |
| 2007 | $90.87 M | -46.27% |
| 2006 | $0.16 B | -4.22% |
| 2005 | $0.17 B | 107.9% |
| 2004 | $84.93 M | -39.45% |
| 2003 | $0.14 B | 5.62% |
| 2002 | $0.13 B | -47.63% |
| 2001 | $0.25 B |
End of Day market cap according to different sources
On Mar 23rd, 2023 the market cap of Sarepta Therapeutics was reported to be:
$11.26 Billion
$11.29 Billion
$11.26 Billion
$11.30 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $99.99 B | 772.50% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $3.28 B | -71.38% | 🇺🇸 USA |
 Novavax NVAX | $0.52 B | -95.40% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $23.62 B | 106.14% | 🇺🇸 USA |
 Insmed INSM | $2.25 B | -80.35% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $1.60 B | -85.97% | 🇺🇸 USA |
 Avidity Biosciences RNA | $1.42 B | -87.58% | 🇺🇸 USA |